COVID Vaccinations: Practical and Ethical Considerations

Rating: 

Average: 5 (1 vote)

Date: 

Tuesday, 02 March 2021

Presenter(s): 

 

Description

The COVID-19 crisis has particular implications for Survivors of Torture programs and non-hospital-based organizations are starting to ask questions about safely providing services now that vaccination is possible for many staff and clients. What are the ethical considerations about safely returning to in-person services? Do we need to mandate that staff get vaccinated? Clients? Can we still infect others if we have been vaccinated? How can we as providers assure our clients have current and accurate information on vaccination?

In this webinar, Dr. Rajeev Bais and Dr. Edwin Hayes of the University of South Carolina School of Medicine Carolina Survivor Clinic in Columbia, SC, draw on their experience in both hospital-based and community clinic-based work to present a brief description of the COVID-19 virus, its prevalence, and treatment. They also provide up-to-date information on vaccination, considerations for providing vaccination information in a multi-cultural environment, and approaches for addressing vaccine and equity concerns among underserved clients.

Objectives

After attending this webinar participants will:

  1. Have new tools for developing or strengthening their program’s approach to COVID vaccination
  2. Be able to recognize current and novel treatment options for COVID-19
  3. Be able to identify good practices and ethical considerations for talking with clients about COVID-19 vaccinations
  4. Be able to locate resources to help themselves and their clients obtain accurate information on COVID-19
  5. Learn/adapt approaches for addressing vaccine hesitancy and equity concerns among underserved clients

PowerPoint

Resources

Multilingual Resources on COVID-19

  • Switchboard: A Round-Up of Multilingual Resources on COVID-19 https://switchboardta.org/blog/a-round-up-of-multilingual-resources-on-covid-19/
  • National Resource Center for Refugees, Immigrants, and Migrants (NRC-RIM) Translated Materials Library https://nrcrim.umn.edu/health-education/translated-materials-library
  • Emergency Use Authorization (EUA) factsheets for the Pfizer and Modern COVID-19 Vaccine. Please note that the languages bolded are *new* updates.
    • Pfizer-BioNTech COVID-19 Vaccine | FDA
      • Translated factsheets for recipients and caregivers.
      • When you enter the site, make sure to scroll down to the bottom of the webpage for hyperlinks to the translated languages below.
      • Available in Arabic, Burmese, Cherokee, Chuukese, Chinese, French, German, Haitian Creole, Hindi, Hmong, lu Mien, Khmer, Korean, Mam, Marshallese, Navajo, Polish, Portuguese, Russian, Spanish, Somali, Tagalog, Vietnamese, Yiddish.
    • Moderna COVID-19 Vaccine | FDA
      • Translated factsheets for recipients and caregivers.
      • When you enter the site, make sure to scroll down to the bottom of the webpage for hyperlinks to the translated languages below.
      • Available in Arabic, Burmese, Cherokee, Chuukese, Chinese, French, German, Haitian Creole, Hindi, Hmong, lu Mien, Khmer, Korean, Mam, Marshallese, Navajo, Polish, Portuguese, Russian, Spanish, Somali, Tagalog, Vietnamese, Yiddish.
  • CDC Communication Toolkit For Migrants, Refugees, and Other Limited-English-Proficient Populations (doesn’t list vaccine) https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/communication-toolkit.html

References

Priyanka, Choudary, O.P, Singh, I. (2021) Protective immunity against COVID-19: Unravelling the evidences for humoral vs. celluar components Travel Travel Med Infect Dis. 2021 January-February; 39: 101911.
Published online 2020 Nov 10. doi: 10.1016/j.tmaid.2020.101911
PMCID: PMC7654327
PMID: 33186686
 
Satish Chandra Pandey, Veni Pande, Diksha Sati, Shobha Upreti, Mukesh Samant, (2020) Vaccination strategies to combat novel corona virus SARS-CoV-2 Life Sciences Volume 256, 1 September 2020, 117956

Rambaut, A. et al, B.1.1.7 Variant COVID-19 Genomics Consortium U.K.

CDC Morbidity and Mortality Weekly, First Month of COVID-19 Vaccine Safety Monitoring – United States, December 14, 2020-January 13, 2021

Attachment(s): 

Add new comment